Latest news about Shree Pacetronix
Shree Pacetronix
143.95
+1.45(+1.02%)
Company Performance:
View Company Insights1D+1.02%
1M+8.89%
6M-39.49%
1Y+75.76%
5Y+1,466.38%
More news about Shree Pacetronix
25Mar 26
Shree Pacetronix Promoter Acquires 1.65L Shares, Files SEBI Disclosure
Shree Pacetronix Limited has completed a significant equity transaction where promoter Akash Sethi acquired 1,65,355 shares through off-market transfer from Bio Pace Technology INC on March 20, 2026. This acquisition increased his shareholding from 4.35% to 8.76%, triggering mandatory SEBI disclosure requirements. The company officially filed the regulatory disclosure with BSE Limited on March 24, 2026, providing comprehensive details of the transaction and updated shareholding structure.
14Feb 26
Biofil Chemicals and Pharmaceuticals Ltd Announces Q3 FY26 Financial Results
Biofil Chemicals and Pharmaceuticals Ltd reported Q3 FY26 results with total income of Rs. 93.46 lakhs and net profit after tax of Rs. 7.92 lakhs. The company's performance showed a decline compared to Q3 FY25 when it recorded total income of Rs. 1421.82 lakhs and net profit of Rs. 16.46 lakhs. Equity share capital remained stable at Rs. 1627.38 lakhs with earnings per share of Rs. 0.05 for the quarter.
22Jan 26
Shree Pacetronix Limited Receives BSE Trading Approval for 75,150 Preferential Equity Shares
Shree Pacetronix Limited has successfully received BSE trading approval for 75,150 equity shares issued to promoters on preferential basis at ₹81 per share, effective January 22, 2026. The shares carry a face value of ₹10 with a premium of ₹71, representing a total value of ₹60.87 crores. The cardiac pacing technology company, celebrating 25 years of operations, completed all regulatory requirements under SEBI Listing Regulations for this corporate action.
07Jan 26
Dheeraj Kumar Lohia Increases Stake in Shree Pacetronix Ltd to 5.25% Through Open Market Purchase
Dheeraj Kumar Lohia disclosed acquisition of 18,400 shares (0.47%) in Shree Pacetronix Ltd through open market purchase on January 5, 2026. His total shareholding increased from 4.78% to 5.25% following this transaction. The acquirer is not part of the promoter group and has several persons acting in concert. The disclosure was filed under SEBI Takeover Regulations from Ghaziabad on January 7, 2026.
27Nov 25
Vivro Financial Services Publishes Post-Offer Advertisement for Shree Pacetronix Open Offer
Shree Pacetronix Limited has received a post-offer advertisement for an open offer to acquire up to 9,75,000 equity shares (26% of expanded share capital) at Rs. 100 per share. The offer is made by Akash Sethi as the Acquirer, with Atul Kumar Sethi, Amita Sethi, and Ashish Sethi as Persons Acting in Concert. The tendering period is from October 25, 2025, to November 14, 2025. The offer complies with SEBI SAST Regulations, and the Committee of Independent Directors has deemed it fair and reasonable.
17Nov 25
Akash Sethi Strengthens Stake in Shree Pacetronix Through Preferential Allotment
Akash Sethi, a promoter group member of Shree Pacetronix Limited, acquired 75,150 equity shares and 2,25,450 warrants through preferential allotment, representing 7.71% of the company's fully diluted share capital. This increased Sethi's personal stake from 0.35% to 8.03% and raised the promoter group's total holding from 24.25% to 30.09%. The transaction, valued at ₹2,43,48,600, has modified the company's capital structure, with the total diluted share capital now at ₹3,90,00,000.
01Nov 25
Shree Pacetronix Reports Robust Q2 FY26 Performance with 187% Profit Surge
Shree Pacetronix Limited, a life-saving devices manufacturer, reported impressive Q2 FY26 results. Revenue from operations increased by 62.76% to Rs. 658.18 lakhs. Net profit soared by 6267.46% to Rs. 187.88 lakhs. Earnings per share rose to Rs. 5.22 from Rs. 0.08 in Q2 FY25. Half-yearly revenue reached Rs. 1,194.49 lakhs with a net profit of Rs. 198.68 lakhs. The financial results were approved by the Board on November 1, 2025.
27Oct 25
Shree Pacetronix Independent Directors Approve ₹9.75 Crore Open Offer at ₹100 Per Share
The Independent Directors Committee (IDC) of Shree Pacetronix Limited has unanimously recommended the open offer made by Akash Sethi and three persons acting in concert. The offer aims to acquire up to 9,75,000 equity shares (26% of expanded share capital) at ₹100.00 per share, totaling ₹9.75 crore. The IDC, comprising three members, deemed the offer price fair and reasonable under SEBI regulations. The acquirers, already part of the promoter group, intend to support the company's growth. Shareholders are advised to independently evaluate the offer before making decisions.
15Oct 25
Shree Pacetronix Forms Independent Directors Committee for Open Offer Review
Shree Pacetronix Limited has established a committee of independent directors to review and provide recommendations on an open offer by Akash Sethi and associated parties. The offer targets 26% of the company's equity share capital at ₹100.00 per share. The committee, formed in compliance with SEBI regulations, consists of Manali Tongia (Chairman), Somya Chhabra, and Chandragupt Jain. Key dates include the Public Announcement on August 7, Detailed Public Statement on August 14, and Draft Letter of Offer on August 21.
07Aug 25
Akash Sethi Launches Open Offer for Shree Pacetronix Limited at ₹100 Per Share
Akash Sethi and persons acting in concert have initiated a mandatory open offer to acquire up to 9,75,000 equity shares (26%) of Shree Pacetronix Limited at ₹100 per share. The offer, valued at ₹9.75 crore, follows a Securities Subscription Agreement for a preferential issue. The acquirer group's stake could increase from 24.25% to 55.09% post-offer, assuming full acceptance and warrant conversion. Shree Pacetronix, a BSE-listed manufacturer of life-saving devices, will continue under the acquirer group's management post-offer.
07Aug 25
Shree Pacetronix Approves Rs 2.43 Crore Preferential Issue and Reports Strong Quarterly Results
Shree Pacetronix Limited approved a preferential issue to raise Rs 2.43 crore through equity shares and warrants. The company reported a 10.07% increase in revenue and a 79.91% rise in net profit for Q1 FY2026 compared to Q1 FY2025. The board reappointed Atul Kumar Sethi as Managing Director for three years, and the 37th AGM is scheduled for September 3, 2025. The company's stock saw significant movement on the BSE following these announcements.
Industry Peers
Poly Medicure
Laxmi Dental
Tarsons Products
Osel Devices
Vasa Denticity
Fabtech Technologies
Hemant Surgical Industries
Prevest Denpro
Aprameya Engineering
Nureca
1,400.10
(-0.35%)
230.00
(+0.51%)
210.02
(-0.32%)
500.00
(+2.90%)
440.00
(-0.02%)
151.28
(+1.33%)
374.00
(-1.93%)
381.30
(+0.03%)
163.40
(+0.21%)
235.60
(+1.33%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
